Therapeutics for Huntington’s disease: Paradigmatic, Problematic and Promising

When

4 to 5 p.m., Jan. 16, 2024

Where

Medical Research Building 102

Thomas F Vogt, Ph.D.

Vice President, Drug Discovery 
Genotype & Phenotype Therapeutics Unit 
CHDI Foundation

Thomas F. Vogt

ZOOM
 

Seminar
Research Seminar

Contacts

Linda Restifo
llr@arizona.edu

Attachments

Flyer Thomas Vogt
Sponsor(s)
Graduate Interdisciplinary Program in Neuroscience
Department of Neuroscience, School of Mind, Brain & Behavior

Speaker

Thomas F. Vogt, Ph.D.
Vice-President, Drug Discovery Genotype & Phenotype Therapeutics Unit
CHDI Foundation